Pacific Biosciences
PACB
PACB
88 hedge funds and large institutions have $178M invested in Pacific Biosciences in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $230M → $178M (-$52.9M)
Holders
88
Holding in Top 10
–
Calls
$409K
Puts
$331K
Top Buyers
| 1 | +$2.04M | |
| 2 | +$1.58M | |
| 3 | +$1.12M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$1.09M |
| 5 |
D.E. Shaw & Co
New York
|
+$834K |
Top Sellers
| 1 | -$4.94M | |
| 2 | -$2.2M | |
| 3 | -$1.92M | |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
-$1.54M |
| 5 |
DM
Deerfield Management
New York
|
-$1.45M |